News Update

Two militants killed in gun battles in KashmirMega inferno in cooking oil factory near Jakarta; 9 burnt to deathJapan reports hottest October since 1898CBIC drive: 83 lakh smuggled cigarettes destroyed by Vijayawada; 49 lakhs sticks by Delhi CustomsGreece PM chats with PM Modi; proposes to open up two new consulates in IndiaGovt releases Guidelines for Central Sector Scheme 'NAMO DRONE DIDI'25 hurt as Telangana SRTC bangs into private busOverall Coal Production in Oct month touches 84.45 Million TonneApple to pump in USD 1.5 bn in Globalstar to ratchet up satellite coverageIndian scientists explore limits of quantum theory for arbitrarily massive objectsGST mop-up grows to Rs 1.87 lakh crore in Oct monthGST - Without providing an opportunity of personal hearing, respondent has passed the impugned assessment order - Same is quashed and set aside - Matter remanded for fresh consideration on condition that petitioner pays 10% of disputed tax amount: HCMP Govt reports death of 10 elephants in 3 days; Samples to be examinedGST - Appeal preferred in March 2023 - During pendency of petition seeking expeditious disposal, hearing granted but petitioner did not remain present - Petitioner does not want any hearing - Respondent to pass appropriate order: HC3-yr-old boy Anish Sarkar from Bengal becomes youngest-ever FIDE-rated chess playerGST - Summary of Show Cause Notice in Form GST DRC-01 cannot substitute requirement for proper Show Cause Notice as mandated by Section 73(1): HCUS goes for massive deployments of B-52 bombers & destroyers in West AsiaKVAT - Refund application can be rejected only where requisite documents in support of the application & for considering the same, could not be obtained: HCMauritius plugs social media till polls are overGST - Pre-deposit amount can partially be paid through Electronic Credit Ledger: HCDelhi records warmest October since 1951I-T- Re-assessment cannot be resorted to, where no failure to make full & true disclosure of material facts necessary for assessment is attributed to assessee: ITATBotswana voters eject party ruling for 60 yrsI-T- While calculating income, net income should be considered as taxable income after reducing the expenditure incurred towards earning of such income: ITAT
 
WHO accredits CDSCO, NRAI for functional vaccine regulatory system

By TIOL News Service

EW DELHI, OCT 11, 2024: THE Central Drugs Standard Control Organisation (CDSCO), along with the National Regulatory Authority of India (NRA) and affiliated institutions, has been found to meet the World Health Organization (WHO) published indicators for a functional vaccine regulatory system. This conclusion was reached by a team of international experts from various countries, led by WHO (HQ) in Geneva, following a comprehensive and in-depth scientific review of India's vaccine regulatory system conducted from September 16 to 20, 2024.

Safety, efficacy, and quality are three basic parameters of assessment of vaccines. WHO has established global standards and benchmarks for assurance of vaccine quality through the development of tools and guidelines, benchmarking of the NRA and prequalification programme of vaccines.

The WHO NRA re-benchmarking was aimed to assess and document the status of the India regulatory system in the area of vaccine regulation, re-benchmark the status of the India vaccine regulatory system against the WHO NRA Global Benchmarking Tool (GBT) and measuring the maturity of the system. India has been declared ‘functional' against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI. India's vaccine regulatory system was benchmarked in the year 2017 against Global benchmarking tool (GBT) version V which is now revised to GBT VI with raised bars and stringency in benchmarking criteria.

India retains Maturity Level 3 with highest marks in several functions.

Speaking about this landmark achievement, Ms. Punya Salila Srivastava, Union Health Secretary, stated, "The Central Drugs Standards Control Organization, in collaboration with WHO, has made exemplary efforts towards this achievement. India is one of the main players in the pharmaceutical industry worldwide and is known for its affordable vaccines and generic medicines."

She also congratulated all the teams for their hard work in achieving this milestone for the country and reemphasized the strength of the Indian regulatory system and its commitment to supplying quality products worldwide to enhance health outcomes.

Dr Roderico H. Ofrin, WHO Representative to India noted, "The WHO plays a pivotal role in supporting countries in strengthening their regulatory systems, and promoting equitable access to quality, safe, efficacious, and affordable medical products and health products. This is indeed a great achievement, and we would like to congratulate the Ministry of Health & Family Welfare and its affiliated institutions," he added.

Dr Rajeev Singh Raghuvanshi, Drugs Controller General (India), Central Drugs Standard Control Organization, MoHFW highlighted that "India, as a large vaccine producing country, is currently supplying several vaccines to the UN agencies (UNICEF, WHO and PAHO)". "National Regulatory Authority of India meets the standards of the WHO NRA indicators (WHO Global benchmarking Tool) on functional regulatory system for vaccines" he added.

In addition to the general framework for the system, the following regulatory functions were evaluated: General Overview of the National Regulatory System (RS), Registration and Marketing Authorization (MA), Vigilance (VL), Market Surveillance and Control (MSC), Licensing Establishments (LI), Regulatory Inspections (RI), Laboratory Testing (LT), Clinical Trials Oversight (CT) and NRA Lot Release (LR).

Welcoming the positive outcome of international benchmarking, Dr Alireza Khadem, WHO Team Leader for the NRA Re-benchmarking, said, "It will go a long way in re-affirming India's role in global health, including the strength of its pharmaceutical sector and drug regulatory capacity. WHO had scaled up its technical support to the India's national regulatory authority over the past several years. This success is a culmination of intensive effort by the Health Ministry, including CDSCO, in collaboration with WHO, to implement a roadmap to strengthen capacity for regulation of vaccines,".

India is a major vaccine producer that has 36 major vaccine manufacturing facilities. These vaccines are used for the national and international market (150 countries), which makes India a major vaccine supplier across the globe.

The WHO Prequalification Programme (PQP) is aimed at facilitating access to vaccines that meet unified standards of quality, safety and efficacy as well as programme needs. It is also prerequisite for manufacturers to supply to countries through United Nations procuring agencies. A functional NRA is a criterion for WHO prequalification of vaccines.

As for all NRA benchmarking, sustainability of the gains made in regulatory capacity is critical. For this purpose, the team which has just completed the assessment in India has drawn up a detailed Institutional Development Plan. The plan will outline additional activities to be undertaken to further strengthen regulatory capacity in India in the coming years.

World Health Organization carried out assessment of the National Regulatory Authority (NRA) of India comprising the Central Drugs Standard Control Organisation (CDSCO), State Drug Regulatory Authorities, Central Drugs Laboratory, Kasauli; Adverse Events Following Immunization (AEFI) structures at the Central and States levels, Immunization Division, Pharmacovigilance Programme of India, and other relevant institutions engaged in the regulation, control and testing of vaccines.


POST YOUR COMMENTS
   

TIOL Tube Latest

Conferment of TIOL Awards 2024. The event was held on October 1, 2024 at Taj Palace, New Delhi



Technical Session I - Ease of Doing Business: GST on Digital Economy